Presymptomatic Genetic Testing for Hereditary Cancer in Young Adults: a Survey of Young Adults and Parents

Overview

Journal Eur J Hum Genet

Specialty Genetics

Date 2018 Oct 6

PMID 30287899

Citations 6

Authors

Lea Godino

Daniela Turchetti

Leigh Jackson

Catherine Hennessy

Heather Skirton

Affiliations

Soon will be listed here.

Abstract

Presymptomatic testing for hereditary cancer syndromes should involve a considered choice. This may be particularly challenging when testing is undertaken in early adulthood. With the aim of exploring the psychosocial implications of presymptomatic testing for hereditary cancer in young adults and their parents, a cross-sectional survey was designed. Two questionnaires were developed (one for young adults who had considered presymptomatic testing, one for parents). Questionnaires were completed by 152 (65.2%) young adults and 42 (73.7%) parents. Data were analysed using descriptive statistics, inferential testing, and exploratory factor analysis and linear regression analysis. Young adults were told about their potential genetic risk at a mean age of 20 years; in most cases, information was given by a parent, often in an unplanned conversation. Although testing requests were usually made by young adults, the majority of parents felt they had control over the young adult's decision and all felt their children should be tested. Results suggest that some young adults did not understand the implications of the genetic test but complied with parental pressure. Counselling approaches for presymptomatic testing may require modification both for young adults and their parents. Those offering testing need to be aware of the complex pressures that young adults can experience, which can influence their autonomous choices. It is therefore important to emphasise to both parents and young adults that, although testing can bring benefits in terms of surveillance and prevention, young adults have a choice.

Citing Articles

Public perspectives on healthcare professional-directed communication of hereditary genetic risks: a mixed-method systematic review.

Godino L, Turchetti D, Gentili V, Chiari P, Palese A Eur J Hum Genet. 2025; .

PMID: 39900745 DOI: 10.1038/s41431-025-01790-4.

Parent and patient knowledge and attitudes about cancer predisposition syndrome genetic testing in pediatric oncology: Understanding sociodemographic and parent-child differences.

Rapoport C, Masser-Frye D, Mehta S, Choi A, Olfus S, Korhummel M Cancer Rep (Hoboken). 2024; 7(9):e2119.

PMID: 39233650 PMC: 11375323. DOI: 10.1002/cnr2.2119.

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?.

Trevisan L, Godino L, Battistuzzi L, Innella G, Luppi E, Buzzatti G Fam Cancer. 2023; 23(2):197-207.

PMID: 37968543 DOI: 10.1007/s10689-023-00349-w.

A Focused Clinical Review of Lynch Syndrome.

Georgiou D, Monje-Garcia L, Miles T, Monahan K, Ryan N Cancer Manag Res. 2023; 15:67-85.

PMID: 36699114 PMC: 9868283. DOI: 10.2147/CMAR.S283668.

Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.

Vibert R, Lahlou-Laforet K, Samadi M, Krivosic V, Blanc T, Amar L Eur J Hum Genet. 2022; 30(10):1171-1177.

PMID: 35918537 PMC: 9553881. DOI: 10.1038/s41431-022-01157-z.

References

Metcalfe A, Coad J, Plumridge G, Gill P, Farndon P . Family communication between children and their parents about inherited genetic conditions: a meta-synthesis of the research. Eur J Hum Genet. 2008; 16(10):1193-200. DOI: 10.1038/ejhg.2008.84. View

Bradbury A, Dignam J, Ibe C, Auh S, Hlubocky F, Cummings S . How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol. 2007; 25(24):3705-11. DOI: 10.1200/JCO.2006.09.1900. View

Tercyak K, Peshkin B, DeMarco T, Brogan B, Lerman C . Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns. 2002; 47(2):145-53. DOI: 10.1016/s0738-3991(01)00192-6. View

Metcalfe A, Plumridge G, Coad J, Shanks A, Gill P . Parents' and children's communication about genetic risk: a qualitative study, learning from families' experiences. Eur J Hum Genet. 2011; 19(6):640-6. PMC: 3097166. DOI: 10.1038/ejhg.2010.258. View

Patenaude A, Dorval M, DiGianni L, Schneider K, Chittenden A, Garber J . Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006; 24(4):700-6. DOI: 10.1200/JCO.2005.01.7541. View

Meissen G, Mastromauro C, Kiely D, McNamara D, Myers R . Understanding the decision to take the predictive test for Huntington disease. Am J Med Genet. 1991; 39(4):404-10. DOI: 10.1002/ajmg.1320390408. View

Shiloh S, Avdor O, Goodman R . Satisfaction with genetic counseling: dimensions and measurement. Am J Med Genet. 1990; 37(4):522-9. DOI: 10.1002/ajmg.1320370419. View

Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A . Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Ann Oncol. 2004; 15 Suppl 1:I48-I54. DOI: 10.1093/annonc/mdh658. View

. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Am J Hum Genet. 1995; 57(5):1233-41. PMC: 1801355. View

10.

Godino L, Turchetti D, Jackson L, Hennessy C, Skirton H . Impact of presymptomatic genetic testing on young adults: a systematic review. Eur J Hum Genet. 2015; 24(4):496-503. PMC: 4929872. DOI: 10.1038/ejhg.2015.153. View

11.

Werner-Lin A, Ratner R, Hoskins L, Lieber C . A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome. J Genet Couns. 2014; 24(1):78-87. DOI: 10.1007/s10897-014-9739-y. View

12.

Gaff C, Lynch E, Spencer L . Predictive testing of eighteen year olds: counseling challenges. J Genet Couns. 2006; 15(4):245-51. DOI: 10.1007/s10897-006-9028-5. View

13.

Rindfuss R . The young adult years: diversity, structural change, and fertility. Demography. 1991; 28(4):493-512. View

14.

Evans J, Skrzynia C, Burke W . The complexities of predictive genetic testing. BMJ. 2001; 322(7293):1052-6. PMC: 1120190. DOI: 10.1136/bmj.322.7293.1052. View

15.

Godino L, Jackson L, Turchetti D, Hennessy C, Skirton H . Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study. Eur J Hum Genet. 2017; 26(1):44-53. PMC: 5839040. DOI: 10.1038/s41431-017-0030-1. View

16.

Hamilton R, Williams J, Bowers B, Calzone K . Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns. 2008; 18(2):147-59. PMC: 2834272. DOI: 10.1007/s10897-008-9200-1. View

17.

Beery T, Williams J . Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genet Test. 2007; 11(2):111-23. DOI: 10.1089/gte.2006.0527. View

18.

Baig S, Strong M, Rosser E, Taverner N, Glew R, Miedzybrodzka Z . 22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium. Eur J Hum Genet. 2016; 24(10):1396-402. PMC: 5027682. DOI: 10.1038/ejhg.2016.36. View

19.

Duncan R, Gillam L, Savulescu J, Williamson R, Rogers J, Delatycki M . "Holding your breath": interviews with young people who have undergone predictive genetic testing for Huntington disease. Am J Med Genet A. 2007; 143A(17):1984-9. DOI: 10.1002/ajmg.a.31720. View

20.

Duncan R, Gillam L, Savulescu J, Williamson R, Rogers J, Delatycki M . The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer. 2009; 9(1):27-35. DOI: 10.1007/s10689-009-9294-0. View